Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients
Top Cited Papers
Open Access
- 1 January 2020
- journal article
- research article
- Published by Taylor & Francis Ltd in Emerging Microbes & Infections
- Vol. 9 (1), 940-948
- https://doi.org/10.1080/22221751.2020.1762515
Abstract
The emerging COVID-19 caused by SARS-CoV-2 infection poses severe challenges to global public health. Serum antibody testing is becoming one of the critical methods for the diagnosis of COVID-19 patients. We investigated IgM and IgG responses against SARS-CoV-2 nucleocapsid (N) and spike (S) protein after symptom onset in the intensive care unit (ICU) and non-ICU patients. 130 blood samples from 38 COVID-19 patients were collected. The levels of IgM and IgG specific to N and S protein were detected by ELISA. A series of blood samples were collected along the disease course from the same patient, including 11 ICU patients and 27 non-ICU patients for longitudinal analysis. N and S specific IgM and IgG (N-IgM, N-IgG, S-IgM, S-IgG) in non-ICU patients increased after symptom onset. N-IgM and S-IgM in some non-ICU patients reached a peak in the second week, while N-IgG and S-IgG continued to increase in the third week. The combined detection of N and S specific IgM and IgG could identify up to 75% of SARS-CoV-2 infected patients in the first week. S-IgG was significantly higher in non-ICU patients than in ICU patients in the third week. In contrast, N-IgG was significantly higher in ICU patients than in non-ICU patients. The increase of S-IgG positively correlated with the decrease of C-reactive protein (CRP) in non-ICU patients. N and S specific IgM and IgG increased gradually after symptom onset and can be used for detection of SARS-CoV-2 infection. Analysis of the dynamics of S-IgG may help to predict prognosis.Keywords
Funding Information
- National Natural Science Foundation of China (82041014)
This publication has 36 references indexed in Scilit:
- Structure, Function, and Evolution of Coronavirus Spike ProteinsAnnual Review of Virology, 2016
- The Coronavirus Nucleocapsid Is a Multifunctional ProteinViruses, 2014
- The SARS coronavirus nucleocapsid protein – Forms and functionsAntiviral Research, 2014
- Immunoreactivity characterisation of the three structural regions of the human coronavirus OC43 nucleocapsid protein by Western blot: Implications for the diagnosis of coronavirus infectionJournal of Virological Methods, 2013
- The Coronavirus Nucleocapsid Protein Is Dynamically Associated with the Replication-Transcription ComplexesJournal of Virology, 2010
- Evaluation of a recombinant nucleocapsid protein‐based assay for Anti‐SARS‐CoV IgG detectionJournal of Medical Virology, 2004
- Antibody Response of Patients with Severe Acute Respiratory Syndrome (SARS) Targets the Viral NucleocapsidThe Journal of Infectious Diseases, 2004
- Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunityProceedings of the National Academy of Sciences of the United States of America, 2004
- Coronavirus Spike Proteins in Viral Entry and PathogenesisVirology, 2001
- Virus maturation by budding.1998